Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

t(14;18)(q32;q21) in chronic lymphocytic leukemia patients: Report of two cases and a literature review.

Chen W, Miao Y, Wang R, Wu Y, Qiu H, Xu W, Li J, Fan L, Xu X.

Oncol Lett. 2016 Dec;12(6):4351-4356. doi: 10.3892/ol.2016.5258. Epub 2016 Oct 13.

2.

Identifying High-Risk Chronic Lymphocytic Leukemia: A Pathogenesis-Oriented Appraisal of Prognostic and Predictive Factors in Patients Treated with Chemotherapy with or without Immunotherapy.

Martinelli S, Cuneo A, Formigaro L, Cavallari M, Lista E, Quaglia FM, Ciccone M, Bardi A, Volta E, Tammiso E, Saccenti E, Sofritti O, Daghia G, Negrini M, Dabusti M, Tomasi P, Moretti S, Cavazzini F, Rigolin GM.

Mediterr J Hematol Infect Dis. 2016 Oct 15;8(1):e2016047. eCollection 2016 Oct 15. Review.

3.

Synergy: karyotypes and mutations in CLL.

Abruzzo LV.

Blood. 2016 Jul 21;128(3):319-20. doi: 10.1182/blood-2016-06-719898. No abstract available.

PMID:
27445409
4.

Comprehensive chronic lymphocytic leukemia diagnostics by combined multiplex ligation dependent probe amplification (MLPA) and interphase fluorescence in situ hybridization (iFISH).

Alhourani E, Rincic M, Othman MA, Pohle B, Schlie C, Glaser A, Liehr T.

Mol Cytogenet. 2014 Nov 19;7(1):79. doi: 10.1186/s13039-014-0079-2. eCollection 2014 Nov 19.

5.

Chronic Lymphocytic Leukemia with t(14;18)(q32;q21) As a Sole Cytogenetic Abnormality.

Elyamany G, Fadalla K, Elghezal H, Alsuhaibani O, Osman H, Al-Abulaaly A.

Clin Med Insights Pathol. 2014 Sep 23;7:21-7. doi: 10.4137/CPath.S17818. eCollection 2014 Sep 23.

6.

Genetic abnormalities in chronic lymphocytic leukemia: where we are and where we go.

Puiggros A, Blanco G, Espinet B.

Biomed Res Int. 2014;2014:435983. doi: 10.1155/2014/435983. Epub 2014 May 22. Review.

7.

Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.

Pei J, Robu V, Feder M, Cheung M, Neumann-Domer E, Talarchek J, Dulaimi E, Millenson MM, Testa JR.

Cancer Genet. 2014 Mar;207(3):98-102. doi: 10.1016/j.cancergen.2014.02.005. Epub 2014 Feb 15.

8.

Genomic variation by whole-genome SNP mapping arrays predicts time-to-event outcome in patients with chronic lymphocytic leukemia: a comparison of CLL and HapMap genotypes.

Schweighofer CD, Coombes KR, Majewski T, Barron LL, Lerner S, Sargent RL, O'Brien S, Ferrajoli A, Wierda WG, Czerniak BA, Medeiros LJ, Keating MJ, Abruzzo LV.

J Mol Diagn. 2013 Mar;15(2):196-209. doi: 10.1016/j.jmoldx.2012.09.006. Epub 2012 Dec 27.

9.

A Japanese case of chronic lymphocytic leukemia with t (1;6).

Harada K, Ikeda K, Matsumoto H, Furukawa M, Takahashi H, Ohkawara H, Noji H, Tasaki K, Abe M, Ogawa K, Takeishi Y.

Exp Hematol Oncol. 2012 Sep 12;1(1):28. doi: 10.1186/2162-3619-1-28.

10.

Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.

Nguyen-Khac F, Lambert J, Chapiro E, Grelier A, Mould S, Barin C, Daudignon A, Gachard N, Struski S, Henry C, Penther D, Mossafa H, Andrieux J, Eclache V, Bilhou-Nabera C, Luquet I, Terre C, Baranger L, Mugneret F, Chiesa J, Mozziconacci MJ, Callet-Bauchu E, Veronese L, Blons H, Owen R, Lejeune J, Chevret S, Merle-Beral H, Leblondon V; Groupe Français d'Etude de la Leucémie Lymphoïde Chronique et Maladie de Waldenström (GFCLL/MW).; Groupe Ouest-Est d’étude des Leucémie Aiguës et Autres Maladies du Sang (GOELAMS).; Groupe d’Etude des Lymphomes de l’Adulte (GELA)..

Haematologica. 2013 Apr;98(4):649-54. doi: 10.3324/haematol.2012.070458. Epub 2012 Oct 12.

11.
12.

Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia.

Byrd JC, Kipps TJ, Flinn IW, Cooper M, Odenike O, Bendiske J, Rediske J, Bilic S, Dey J, Baeck J, O'Brien S.

Leuk Lymphoma. 2012 Nov;53(11):2136-42. doi: 10.3109/10428194.2012.681655. Epub 2012 Jun 12.

13.

Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.

Nguyen-Khac F, Chapiro E, Lesty C, Grelier A, Luquet I, Radford-Weiss I, Lefebvre C, Fert-Ferrer S, Callet-Bauchu E, Lippert E, Raggueneau V, Michaux L, Barin C, Collonge-Rame MA, Mugneret F, Eclache V, Taviaux S, Dastugue N, Richebourg S, Struski S, Talmant P, Baranger L, Gachard N, Gervais C, Quilichini B, Settegrana C, Maloum K, Davi F, Merle-Béral H.

Am J Blood Res. 2011;1(1):13-21. Epub 2011 Apr 15.

14.

Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies.

Duhoux FP, Ameye G, Lambot V, Herens C, Lambert F, Raynaud S, Wlodarska I, Michaux L, Roche-Lestienne C, Labis E, Taviaux S, Chapiro E, Nguyen-Khac F, Struski S, Dobbelstein S, Dastugue N, Lippert E, Speleman F, Van Roy N, De Weer A, Rack K, Talmant P, Richebourg S, Mugneret F, Tigaud I, Mozziconacci MJ, Laibe S, Nadal N, Terré C, Libouton JM, Decottignies A, Vikkula M, Poirel HA; Groupe Francophone de Cytogénétique Hématologique (GFCH).; Belgian Cytogenetic Group for Hematology and Oncology (BCG-HO)..

PLoS One. 2011;6(10):e26311. doi: 10.1371/journal.pone.0026311. Epub 2011 Oct 21. Erratum in: PLoS One. 2011 Dec 13;6(12). doi: 10.1371/annotation/3b5aaa87-72b6-49d3-9ec9-f4a656e12e3a. Khac, Florence Nguyen [corrected to Nguyen-Khac, Florence].

15.

Acquired genomic copy number aberrations and survival in chronic lymphocytic leukemia.

Ouillette P, Collins R, Shakhan S, Li J, Peres E, Kujawski L, Talpaz M, Kaminski M, Li C, Shedden K, Malek SN.

Blood. 2011 Sep 15;118(11):3051-61. doi: 10.1182/blood-2010-12-327858. Epub 2011 Jul 27.

16.

Enhanced detection of chromosomal abnormalities in chronic lymphocytic leukemia by conventional cytogenetics using CpG oligonucleotide in combination with pokeweed mitogen and phorbol myristate acetate.

Muthusamy N, Breidenbach H, Andritsos L, Flynn J, Jones J, Ramanunni A, Mo X, Jarjoura D, Byrd JC, Heerema NA.

Cancer Genet. 2011 Feb;204(2):77-83. doi: 10.1016/j.cancergen.2010.12.006.

17.

A rare case of t(11;22) in a mantle cell lymphoma like B-cell neoplasia resulting in a fusion of IGL and CCND1: case report.

Rocha CK, Praulich I, Gehrke I, Hallek M, Kreuzer KA.

Mol Cytogenet. 2011 Apr 1;4(1):8. doi: 10.1186/1755-8166-4-8.

18.

Biological evaluation of CpG stimulation of normal human B-cells: implications for B-cell biology and cytogenetic analysis of CLL B-cells.

Wu X, Smoley SA, Peterson MA, Walters DK, Arendt BK, Nowakowski GS, Van Dyke DL, Kay NE, Jelinek DF.

Br J Haematol. 2011 May;153(3):402-5. doi: 10.1111/j.1365-2141.2010.08514.x. Epub 2011 Feb 17. No abstract available.

19.

A pathobiological role of the insulin receptor in chronic lymphocytic leukemia.

Saiya-Cork K, Collins R, Parkin B, Ouillette P, Kuizon E, Kujawski L, Erba H, Campagnaro E, Shedden K, Kaminski M, Malek SN.

Clin Cancer Res. 2011 May 1;17(9):2679-92. doi: 10.1158/1078-0432.CCR-10-2058. Epub 2011 Feb 9.

20.

Stimulation of chronic lymphocytic leukemia cells with CpG oligodeoxynucleotide gives consistent karyotypic results among laboratories: a CLL Research Consortium (CRC) Study.

Heerema NA, Byrd JC, Dal Cin PS, Dell' Aquila ML, Koduru PR, Aviram A, Smoley SA, Rassenti LZ, Greaves AW, Brown JR, Rai KR, Kipps TJ, Kay NE, Van Dyke DL; Chronic Lymphocytic Leukemia Research Consortium..

Cancer Genet Cytogenet. 2010 Dec;203(2):134-40. doi: 10.1016/j.cancergencyto.2010.07.128.

Supplemental Content

Support Center